Compare
XCF Global, Inc. vs Alto Ingredients, Inc. vs Aemetis, Inc vs Gevo, Inc.
| Latest fiscal year | XCF Global, Inc. SAFXRevenue covers only part of its income (partial revenue) | Alto Ingredients, Inc. ALTO | Aemetis, Inc AMTX | Gevo, Inc. GEVO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $917.93M | $197.63M | $160.58M |
| Revenue growth (YoY) | n/a | -4.9% | -26.2% | +849.3% |
| Gross margin | n/a | 3.8% | -0.4% | n/a |
| Operating margin | n/a | 0.8% | -18.8% | -12.6% |
| Net margin | n/a | 1.5% | -39.0% | -21.1% |
| Net income | $74.00M | $13.34M | -$77.00M | -$33.84M |
| EPS (Diluted) | $0.52 | $0.16 | -$1.28 | -$0.14 |
| Operating cash flow | -$17.86M | $13.24M | $3.26M | -$13.40M |
| Free cash flow | n/a | $8.65M | -$22.74M | -$43.51M |
| Cash & equivalents | $154.9K | $23.41M | $4.89M | $81.16M |
| Total assets | $419.47M | $388.79M | $259.84M | $718.93M |
| Total liabilities | $381.82M | $143.54M | n/a | $247.76M |
| Shareholders' equity | $37.65M | $245.24M | -$306.83M | $466.34M |
| Return on year-end equity | 196.5% | 5.4% | n/a | -7.3% |
| Shares outstanding | 206.47M | 77.31M | 66.19M | 242.46M |
Revenue, most recent five fiscal years
| Fiscal year | XCF Global, Inc. | Alto Ingredients, Inc. | Aemetis, Inc | Gevo, Inc. |
|---|---|---|---|---|
| Latest | n/a | $917.93M Ended 2025-12-31 | $197.63M Ended 2025-12-31 | $160.58M Ended 2025-12-31 |
| 1 year earlier | n/a | $965.26M Ended 2024-12-31 | $267.64M Ended 2024-12-31 | $16.91M Ended 2024-12-31 |
| 2 years earlier | n/a | $1.22B Ended 2023-12-31 | $186.72M Ended 2023-12-31 | $17.20M Ended 2023-12-31 |
| 3 years earlier | n/a | $1.34B Ended 2022-12-31 | $256.51M Ended 2022-12-31 | $1.18M Ended 2022-12-31 |
| 4 years earlier | n/a | $1.21B Ended 2021-12-31 | $211.95M Ended 2021-12-31 | $533.0K Ended 2021-12-31 |